Jump to Footer

Shusen Sun

Clinical Assistant Professor, Emergency Medicine
Department of Pharmacy Practice

Email:     ssun@wne.edu
Phone:   413-796-2424
Office:    CSP 425

Dr. Sun was a research scientist at Pfizer prior to his pharmacy career, and received the Pfizer Global Research and Development Excellence Award in 2002 and Discovery Above and Beyond Award in 2005.  He received his PharmD from Creighton University and is a Board Certified Pharmacotherapy Specialist. He has eight years of experience as a clinical pharmacy specialist providing direct patient care in emergency departments. He established comprehensive emergency pharmacy services at Yale New-Haven Hospital- Saint Raphael Campus. In 2011, he took an academic position at the College of Pharmacy.  He was awarded educational grants on drug overdose education in 2014 and 2015, and was the recipient of the College of Pharmacy Excellence in Scholarship award in 2014.  For the past 2 years, Dr. Sun has been delivering presentations at pharmacy and emergency medicine conferences both within and outside of the United States. He speaks on topics ranging from pharmacy service in emergency care to pharmacy education.  

Dr. Sun is currently serving as an Associate Editor to Drug Evaluation, one of the core pharmacy journals in China. He is also a member of the Executive Committee of Chinese Pharmacological Society, Division of Therapeutic Drug Monitoring Research.


  • PHAR 621 Renal Pharmacotherapy
  • PHAR 622 Respiratory Pharmacotherapy
  • PHAR 624 Cardiovascular Pharmacotherapy II
  • PHAR 727 Patient Care Management
  • PHAR 657 Management of Acute Overdose and Poisoning


Dr Sun’s current research focuses on emergency care, therapeutic drug monitoring, drug overdose, and global pharmacy education.

Recent Publications

  1. Zhao Z, Sun S, Editors. Acute overdose and management. 1st ed. Beijing: People’s Medical Publishing House Co. LTD; 2015.

  1. Thomas M, Sun S. Advanced pharmacy practice experiences for pharmacy students in emergency department settings. Currents in Pharmacy Teaching and Learning. 2015;7(3):378-81.

  2. Sun S, Nemec E, Tessier E, Joyce B. Implementing a learner-centered introductory pharmacy practice experience model at a community hospital.  Currents in Pharmacy Teaching and Learning. 2015;7(2):231-38.

  3. Sun S, Ma X, Zhao Z. Updates of new molecular entities approved by FDA in 2014: gastrointestinal, neurological, psoriasis, rare diseases and imaging agent. Drug Evaluation.  2015;12(6):6-12.

  4. Sun S, Han R, Zhao Z. Updates of new molecular entities approved by FDA in 2014: cardiovascular, respiratory and diabetic drugs. Drug Evaluation. 2015;12(4):5-10.

  5. Guo M, Zhao Z, Sun S, Li X. The comparison between novel oral anticoagulants and warfarin in clinical application.  Drug Evaluation.  2015;12(4):24-7.

  6. Sun S, Li X, Han R, Zhao Z. Updates of new molecular entities approved by FDA in 2014: anti-infective agents. Drug Evaluation. 2015;12(2):8-14.

  7. Sun S, Si Y, Zhao Z. Introduction to the US expert guidelines for stocking antidotes in hospitals. Drug Evaluation. 2014;11(22): 11-3.

  8. Sun S, Xi H, Ma X, Zhao Z. Introduction to the Board of Pharmacy Specialty Certification Program in the United States and its revelation for China. Drug Evaluation. 2014;11(20):8-12.

  9. Cannabinoid Hyperemesis Syndrome  S. Sun, A. Zimmermann Hosp Pharm 2013;48(8);650-655

Professional Affiliations

  • American Society of Health-System Pharmacists (ASHP)
  • Society of Critical Care Medicine (SSCM)
  • American Association of Colleges of Pharmacy (AACP)
  • Chinese Pharmacological Society-Division of Therapeutic Drug Monitoring

Practice Area

   Holyoke Medical Center
   Focus: Emergency care